Optimizing multiple sclerosis diagnosis: gene expression and genomic association
Main Authors: | Gurevich, Michael, Miron, Gadi, Achiron, Anat |
---|---|
Format: | Online |
Language: | English |
Published: |
BlackWell Publishing Ltd
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369276/ |
Similar Items
-
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis
by: Gurevich, Michael, et al.
Published: (2015) -
Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
by: Achiron, Anat, et al.
Published: (2009) -
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis
by: Achiron, Anat, et al.
Published: (2012) -
Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
by: Kaminski, Naftali, et al.
Published: (2005) -
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
by: Gurevich, Michael, et al.
Published: (2009)